Hyperbaric oxygen augments susceptibility to C. difficile infection by impairing gut microbiota ability to stimulate the HIF-1α-IL-22 axis in ILC3
ABSTRACTHyperbaric oxygen (HBO) therapy is a well-established method for improving tissue oxygenation and is typically used for the treatment of various inflammatory conditions, including infectious diseases. However, its effect on the intestinal mucosa, a microenvironment known to be physiologicall...
Main Authors: | José L. Fachi, Laís. P. Pral, Helder C. Assis, Sarah Oliveira, Vinícius R. Rodovalho, Jefferson A. C. dos Santos, Mariane F. Fernandes, Valquíria A. Matheus, Renata Sesti-Costa, Paulo J. Basso, Marina Flóro e Silva, Niels O. S. Câmara, Selma Giorgio, Marco Colonna, Marco A. R. Vinolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2023.2297872 |
Similar Items
-
Effects of Hyperbaric Oxygen Therapy for Clostridioides difficile-associated Colitis: A Retrospective Study
by: Daisuke Muroya, et al.
Published: (2023-10-01) -
Transcriptional control of ILC identity
by: Anna A. Korchagina, et al.
Published: (2023-03-01) -
Reviewing the <i>Clostridioides difficile</i> Mouse Model: Insights into Infection Mechanisms
by: José L. Fachi, et al.
Published: (2024-01-01) -
The Metabolic Basis of ILC Plasticity
by: Abigaelle Pelletier, et al.
Published: (2022-04-01) -
Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer
by: Michela Calvi, et al.
Published: (2022-05-01)